Our research and software development focus on monitoring neurological diseases, planning neurosurgical interventions, supporting clinical trials and performing quantitative studies.
Efficiency, reliability and accuracy of software assistants for evaluating neuroimaging data is of paramount importance within clinical settings, where planning results or therapy decisions might depend on individual measurements.
Diseases like brain tumors, arteriovenous malformations, multiple sclerosis or Alzheimer are only a small subset where our qualitative and quantitative neuroimaging techniques have already proven useful.